Literature DB >> 16054351

Several genes in the extended human MHC contribute to predisposition to autoimmune diseases.

Benedicte A Lie1, Erik Thorsby.   

Abstract

Autoimmune diseases, such as type 1 diabetes, rheumatoid arthritis, psoriasis and systemic lupus erythematosus, affect approximately 4% of the population in industrialized countries, and are characterized by an immune-mediated destruction of autologous cells and/or tissues. More knowledge is needed to prevent and treat this large group of diseases. Unravelling the genetic predisposing factors is important in this respect, and large research efforts have been initiated to reach this goal. The human MHC, also called the human leukocyte antigen (HLA) complex, is known to harbour major genetic determinants for autoimmune diseases. For several autoimmune diseases certain classical HLA class II and/or class I genes are strongly associated with disease. As a result of recent systematic screening studies additional genes and regions in the MHC, including the extended MHC, are now known to contribute to the predisposition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054351     DOI: 10.1016/j.coi.2005.07.001

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  22 in total

Review 1.  Genomic architecture of MHC-linked odorant receptor gene repertoires among 16 vertebrate species.

Authors:  Pablo Sandro Carvalho Santos; Thomas Kellermann; Barbara Uchanska-Ziegler; Andreas Ziegler
Journal:  Immunogenetics       Date:  2010-08-03       Impact factor: 2.846

Review 2.  An alternative approach to medical genetics based on modern evolutionary biology. Part 3: HERVs in diseases.

Authors:  Frank P Ryan
Journal:  J R Soc Med       Date:  2009-10       Impact factor: 5.344

Review 3.  Expression regulation and function of NLRC5.

Authors:  Yikun Yao; Youcun Qian
Journal:  Protein Cell       Date:  2013-03-13       Impact factor: 14.870

4.  Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease.

Authors:  Zohreh Tatari-Calderone; Heather Gordish-Dressman; Ross Fasano; Michael Riggs; Catherine Fortier; Andrew D Campbell; Dominique Charron; Victor R Gordeuk; Naomi L C Luban; Stanislav Vukmanovic; Ryad Tamouza
Journal:  Hum Immunol       Date:  2015-10-22       Impact factor: 2.850

Review 5.  Reconsidering the association between the major histocompatibility complex and bipolar disorder.

Authors:  Thalita Cristina Figueiredo; João Ricardo Mendes de Oliveira
Journal:  J Mol Neurosci       Date:  2011-10-11       Impact factor: 3.444

6.  Development of a high-resolution NGS-based HLA-typing and analysis pipeline.

Authors:  Michael Wittig; Jarl A Anmarkrud; Jan C Kässens; Simon Koch; Michael Forster; Eva Ellinghaus; Johannes R Hov; Sascha Sauer; Manfred Schimmler; Malte Ziemann; Siegfried Görg; Frank Jacob; Tom H Karlsen; Andre Franke
Journal:  Nucleic Acids Res       Date:  2015-03-09       Impact factor: 16.971

Review 7.  Epigenetic alterations in autoimmune rheumatic diseases.

Authors:  Esteban Ballestar
Journal:  Nat Rev Rheumatol       Date:  2011-02-22       Impact factor: 20.543

Review 8.  Genetics of primary sclerosing cholangitis and pathophysiological implications.

Authors:  Xiaojun Jiang; Tom H Karlsen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-15       Impact factor: 46.802

9.  Exploring the diabetogenicity of the HLA-B18-DR3 CEH: independent association with T1D genetic risk close to HLA-DOA.

Authors:  I Santin; A Castellanos-Rubio; A M Aransay; G Gutierrez; S Gaztambide; I Rica; J L Vicario; J A Noble; L Castaño; J R Bilbao
Journal:  Genes Immun       Date:  2009-05-21       Impact factor: 2.676

10.  Human leukocyte antigen class II associations with hepatitis C virus clearance and virus-specific CD4 T cell response among Caucasians and African Americans.

Authors:  Rebecca A Harris; Kazushi Sugimoto; David E Kaplan; Fusao Ikeda; Malek Kamoun; Kyong-Mi Chang
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.